Pharmacokinetics of liposomes designed to carry glucocorticoids.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Polish Journal of Pharmacology

• Publication date

  2003-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 14730102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liposome-Based Drug Delivery Systems

  2021cited by this paper
• Delivery of molecular and cellular medicine to solid tumors.

  2001cited by this paper
• Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.

  2001cited by this paper
• Trends and developments in liposome drug delivery systems.

  2001cited by this paper
• Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats.

  2001cited by this paper
• Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development.

  2000cited by this paper
• Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development.

  2000cited by this paper
• Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.

  2000cited by this paper
• In vivo targeting by liposomes.

  2000cited by this paper
• Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.

  2000cited by this paper
• Effect of liposome molecular composition on its ability to carry drugs.

  2000cited by this paper
• Liposome-based drug delivery systems.

  1999cited by this paper
• Liposomes for scintigraphic detection of infection and inflammation.

  1999cited by this paper
• Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration.

  1999cited by this paper
• Diagnostic and Therapeutic Targeting of Infectious and Inflammatory Diseases Using Sterically Stabilized Liposomes

  1998cited by this paper
• Liposomes: quo vadis?

  1998cited by this paper
• Modulation of pharmacokinetic behavior of liposomes

  1997cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• The “Stealth” Liposome: A Prototypical Biomaterial

  1996cited by this paper
• Numerical Recipes in C The Art of Scientific Computing

  1995cited by this paper
• Kinetic analysis of AUC-dependent saturable clearance of liposomes: Mathematical description of AUC dependency

  1993cited by this paper
• Distinction Between the Depletion of Opsonins and the Saturation of Uptake in the Dose-Dependent Hepatic Uptake of Liposomes

  1993cited by this paper
• Numerical Recipes in C: The Art of Scientific Computing

  1989cited by this paper
• Numerical Recipes in C: The Art of Sci-entific Computing

  1986cited by this paper

• Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics

  2012cites this paper
• Vergleichende Analyse der Wirksamkeit synthetischer Glukokortikoide sowie des Wirkmechanismus von Liposomen-verpackten Kortikosteroiden bei der Therapie der Experimentellen Autoimmunen Enzephalitis (EAE) unter Berücksichtigung systemischer Nebenwirkungen

  2011influential citation
• The effect of liposome‐delivered prednisolone on collagen density, myofibroblasts, and fibrous capsule thickness around silicone breast implants in rats

  2010cites this paper
• Drug delivery systems: past, present, and future.

  2004cites this paper